We are live on ! Find out more
MP

Mangrove Partners Portfolio holdings

AUM $1.24B
1-Year Est. Return 41.74%
This Fund
S&P 500
This Quarter Est. Return
+2.12%
1 Year Est. Return
+41.74%
3 Year Est. Return
+169.22%
5 Year Est. Return
+150.23%
10 Year Est. Return
+417.9%
AUM
$971M
AUM Growth
-$19.4M
Cap. Flow
+$172M
Cap. Flow %
17.68%
Top 10 Hldgs %
24.54%
Holding
508
New
199
Increased
44
Reduced
12
Closed
182

Sector Composition

Rank Sector Weight
1 Financials 37.12%
2 Healthcare 13.18%
3 Technology 10.4%
4 Communication Services 6.84%
5 Energy 5.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MIT
101
DELISTED
Mason Industrial Technology, Inc.
MIT
$2.9M 0.3%
300,000
TWLV
102
DELISTED
Twelve Seas Investment Company II Class A Common Stock
TWLV
$2.9M 0.3%
+300,000
New +$2.91M
QDRO
103
DELISTED
Quadro Acquisition One Corp. Class A Ordinary Shares
QDRO
$2.9M 0.3%
+300,000
New +$2.92M
SLCR
104
DELISTED
Silver Crest Acquisition Corporation Class A Ordinary Share
SLCR
$2.9M 0.3%
300,000
HCCC
105
DELISTED
Healthcare Capital Corp. Class A common stock
HCCC
$2.9M 0.3%
300,000
AEON icon
106
AEON Biopharma
AEON
$11.1M
$2.89M 0.3%
+4,167
New +$2.91M
MDH
107
DELISTED
MDH Acquisition Corp.
MDH
$2.89M 0.3%
300,000
ITQ
108
DELISTED
Itiquira Acquisition Corp. Class A Ordinary Shares
ITQ
$2.89M 0.3%
+300,000
New +$2.91M
SPTK
109
DELISTED
SportsTek Acquisition Corp. Class A Common Stock
SPTK
$2.89M 0.3%
+300,000
New +$2.91M
MLGO
110
MicroAlgo
MLGO
$45.6M
$2.88M 0.3%
+48
New +$2.86M
CRXT
111
DELISTED
Clarus Therapeutics Holdings, Inc. Common Stock
CRXT
$2.88M 0.3%
285,460
MACQ
112
DELISTED
MCAP Acquisition Corporation Class A Common Stock
MACQ
$2.87M 0.3%
+298,608
New +$2.9M
PRST
113
DELISTED
Presto Technologies, Inc. Common Stock
PRST
$2.77M 0.29%
279,300
-20,700
-7% -$206K
AGAC
114
DELISTED
African Gold Acquisition Corp
AGAC
$2.74M 0.28%
+284,204
New +$2.75M
JSPR icon
115
Jasper Therapeutics
JSPR
$22.9M
$2.7M 0.28%
27,146
-20,989
-44% -$2.09M
DNZ
116
DELISTED
D and Z Media Acquisition Corp.
DNZ
$2.63M 0.27%
270,779
-29,221
-10% -$286K
AKIC
117
DELISTED
Sports Ventures Acquisition Corp. Class A Ordinary Shares
AKIC
$2.57M 0.26%
264,663
TBCP
118
DELISTED
Thunder Bridge Capital Partners III Inc. Class A Common Stock
TBCP
$2.52M 0.26%
+259,980
New +$2.54M
EQHA
119
DELISTED
EQ Health Acquisition Corp.
EQHA
$2.46M 0.25%
254,900
KBR icon
120
KBR
KBR
$4.68B
$2.44M 0.25%
63,827
BNAI
121
Brand Engagement Network
BNAI
$75.6M
$2.42M 0.25%
+25,000
New +$2.43M
COVA
122
DELISTED
COVA Acquisition Corp. Class A Ordinary Share
COVA
$2.42M 0.25%
+250,000
New +$2.43M
CLRM
123
DELISTED
Clarim Acquisition Corp. Class A Common Stock
CLRM
$2.41M 0.25%
249,999
FINM
124
DELISTED
Marlin Technology Corporation Class A Ordinary Share
FINM
$2.39M 0.25%
246,651
STRE
125
DELISTED
Supernova Partners Acquisition Company III, Ltd.
STRE
$2.32M 0.24%
+238,227
New +$2.33M

Similar funds

Mangrove Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Mangrove Partners held 508 positions worth $971M, down 2% from $991M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Mangrove Partners deployed $172M of net new capital in Q2 2021, opening 199 new positions and adding to 44 existing holdings. Its largest new stake was Coherent Inc: 74,493 shares worth $19.7M.

By sector, the portfolio is most concentrated in Financials at 37% of assets, up from 19% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was GPGI Inc, an estimated $7.25M trimmed.

  • Mangrove Partners's largest Q2 2021 buy was Coherent Inc: 74,493 shares worth $19.7M.
  • Mangrove Partners added most to Pershing Square Tontine Holdings, Ltd. in Q2 2021, an estimated $32.9M increase.
  • Mangrove Partners's biggest Q2 2021 reduction was GPGI Inc, cutting an estimated $7.25M.
  • Mangrove Partners fully exited Alexion Pharmaceuticals in Q2 2021, selling an estimated $17.3M.
  • Mangrove Partners's ten largest holdings make up 25% of its $971M portfolio in Q2 2021.
  • Mangrove Partners opened 199 new positions and closed 182 in Q2 2021.
  • Mangrove Partners's portfolio value fell 2% quarter-over-quarter to $971M.

Based on Mangrove Partners's 13F filing for Q2 2021, filed 16 Aug 2021.